Financials
- Market Capitalization 1.83 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2071 | ZYME Zymeworks Inc. - Common Stock | 24.67 USD | +0.04% | -5.59% | +5.88% | +39.06% | 1.80 B USD | ||
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.35 USD | +0.30% | -9.70% | +2.45% | -36.67% | 1.78 B USD | ||
| 2094 | ZBIO Zenas BioPharma, Inc. - Common Stock | 28.68 USD | -0.35% | +4.25% | +52.88% | +8.39% | 1.81 B USD | ||
| 2117 | IMCR Immunocore Holdings plc - American Depositary Shares | 34.04 USD | +1.70% | +2.62% | +18.98% | +1.67% | 1.73 B USD |